Rhenman & Partners Asset Management Ab Olink Holding Ab (Publ) Transaction History

Rhenman & Partners Asset Management Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$14.45 - $20.34 $2.4 Million - $3.38 Million	166,000 New	166,000 $2.45 Million
Q2 2023 Aug 11, 2023	SELL	$17.13 - $23.74 $142,179 - $197,042	-8,300 Reduced 4.76%	166,000 $3.11 Million
Q1 2023 May 11, 2023	SELL	$19.34 - $24.11 $388,540 - $484,369	-20,090 Reduced 10.33%	174,300 $3.93 Million
Q3 2022 Nov 14, 2022	BUY	$12.14 - $18.42 $660,294 - $1 Million	54,390 Added 38.85%	194,390 $3.56 Million
Q3 2021 Nov 12, 2021	BUY	$23.42 - $37.93 $3.28 Million - $5.31 Million	140,000 New	140,000 $3.4 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.